(Q37467220)

20 August 2017

1 reference

title

Extracorporeal photopheresis: from solid organs to face transplantation (English)

1 reference

20 August 2017

2

Maria Siemionow

1 reference

20 August 2017

Mikaël Hivelin

1

1 reference

PubMed ID

19409991

20 August 2017

Philippe Grimbert

series ordinal

3

1 reference

PubMed ID

19409991

20 August 2017

Laurent Lantieri

series ordinal

4

1 reference

20 August 2017

3 May 2009

1 reference

20 August 2017

Transplant Immunology

1 reference

20 August 2017

21

1 reference

20 August 2017

3

1 reference

20 August 2017

117-128

1 reference

Costimulation blockade with belatacept in renal transplantation

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Outcomes 18 months after the first human partial face transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Ultraviolet light-induced regulatory (suppressor) T cells: an approach for promoting induction of operational allograft tolerance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Tumor suppressor gene mutations and photocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Antigenicity of murine skin tumors induced by ultraviolet light

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Extracorporeal photochemotherapy in the treatment of severe graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

[Extracorporeal photopheresis in therapy-refractory disseminated discoid lupus erythematosus]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Successful treatment of heart transplant rejection with photopheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Extracorporeal photochemotherapy after cardiac transplantation: a new therapeutic approach to allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Extracorporeal Photopheresis in the Treatment of Persistent Rejection in a Pediatric Lung Transplant Recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Avoiding calcineurin inhibitors in the early post-operative course in high-risk liver transplant recipients: The role of extracorporeal photopheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Photopheresis in transplantation: future research and directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

UVA1 radiation triggers two different final apoptotic pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Light and death: photons and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Lymphocytes treated by extracorporeal photopheresis demonstrate a drop in the Bcl-2/Bax ratio: a possible mechanism involved in extracorporeal-photopheresis-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Investigation of annexin V binding to lymphocytes after extracorporeal photoimmunotherapy as an early marker of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Extracorporeal photopheresis: a focus on apoptosis and cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

The phagocytosis of apoptotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

7 January 2021

Apoptotic cell removal

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Mechanisms of apoptosis: UVA1-induced immediate and UVB-induced delayed apoptosis in human T cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Immunosuppressive effects of apoptotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Mediators involved in the immunomodulatory effects of apoptotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Phagocyte recognition of cells undergoing apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Photopheresis: clinical applications and mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

The putative role of apoptosis in the induction of pemphigus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Pathogenesis of cutaneous lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Apoptosis in the pathogenesis of systemic lupus erythematosus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Treatment of T lymphocytes with 8-methoxypsoralen plus ultraviolet A induces transient but biologically active Th1-skewing cytokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Early reduction in number of T cells producing proinflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Ultraviolet-irradiated apoptotic lymphocytes produce interleukin-10 by themselves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Immunologic parameters of ultraviolet carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Studies into the transplantation biology of ultraviolet light-induced tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Evidence for the generation of suppressor cells by ultraviolet radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Specific suppression of allograft rejection after treatment of recipient mice with ultraviolet radiation and allogeneic spleen cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Differential immune response of congenic mice to ultraviolet-treated major histocompatibility complex class II-incompatible skin grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Induction of regulatory T cells after prophylactic treatment with photopheresis in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Regulatory T cells induced by ultraviolet radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

The role of IL-4, IL-10, and TNF-alpha in the immune suppression induced by ultraviolet radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Potential mechanisms of photopheresis in hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Immunomodulation in transplantation with photopheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Photopheresis immunomodulation after heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Extracorporeal photopheresis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Treatment of graft versus host disease (GVHD) by photopheresis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Severe intestinal graft versus host disease after donor lymphocyte infusion; response to extracorporeal photochemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Chronic graft versus host disease of oral mucosa: review of available therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Mechanisms of action of extracorporeal photochemotherapy in the control of GVHD: involvement of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Photopheresis for the treatment of refractory renal graft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Photopheresis for recurrent acute rejection in cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Refractory acute renal allograft rejection successfully treated with photopheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Prolongation of rat renal allograft survival time by donor pretreatment with 8-methoxypsoralen and longwave ultraviolet irradiation of the graft (PUVA therapy)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Primate cardiac allo-and xenotransplantation: modulation of the immune response with photochemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Photopheresis for renal allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Renal allograft rejection controlled by photopheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Benefits of photopheresis in the treatment of heart transplant patients with multiple/refractory rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Rejection With Hemodynamic Compromise: Objective Evidence for Efficacy of Photopheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Immunosuppression for lung transplantation: evidence to date

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Photopheresis for chronic rejection of lung allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Successful reversal of recalcitrant hepatic allograft rejection by photopheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Liver transplants contribute to their own success

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

The mystique of hepatic tolerogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

The "privileged" liver and hepatic tolerogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Potential applications of extracorporeal photopheresis in liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Optimizing bexarotene therapy for cutaneous T-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Cutaneous T cell lymphoma: update of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Side-effects and complications in large-bore catheters for apheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Heparin low . . . photo no!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Feasibility of photopheresis to reduce the occurrence of restenosis after percutaneous transluminal coronary angioplasty: a clinical pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

HLA-mismatched renal transplantation without maintenance immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Chimerism and tolerance in a recipient of a deceased-donor liver transplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Combined islet and hematopoietic stem cell allotransplantation: a clinical pilot trial to induce chimerism and graft tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Transplantation of the abdominal wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Clinicopathologic features of graft rejection of the first human hand allograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

The International Registry on Hand and Composite Tissue Transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Second report (1998-2006) of the International Registry of Hand and Composite Tissue Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

First human double hand transplantation: efficacy of a conventional immunosuppressive protocol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

The indirect effects of cytomegalovirus infection on the outcome of organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Acceleration of allograft failure by cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Cytomegalovirus-related complications in human hand transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Absence of graft-versus-host disease in the isolated vascularized bone marrow transplant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

First human face allograft: early report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Relative antigenicity of components of a vascularized limb allograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

Extracorporeal photochemotherapy for the treatment of graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.04.005

10.1016/J.TRIM.2009.04.005

7 January 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19409991